Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

BACKGROUND: To explore clinical characteristics and treatment reasons for intravitreal injection of antivascular endothelial growth factor (anti-VEGF) drugs in the treatment of nontype 1 retinopathy of prematurity (ROP). METHODS: A retrospective study was conducted to screen the nontype 1 ROP from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haitao, Yang, Xin, Zheng, Fangfang, Yin, Xiangke, Wan, Suhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705111/
https://www.ncbi.nlm.nih.gov/pubmed/36452412
http://dx.doi.org/10.1155/2022/6266528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705111/
https://www.ncbi.nlm.nih.gov/pubmed/36452412
http://dx.doi.org/10.1155/2022/6266528

Ejemplares similares